Top

Hereditary Cancer in Clinical Practice

Published in:

Open Access 01-12-2023 | Anxiety | Case Report

Familial pancreatic cancer: a case study and review of the psychosocial effects of diagnoses on families

Authors: Tracy Lowe, Jane DeLuca, Ludovico Abenavoli, Luigi Boccuto

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2023

Abstract

Background

Familial pancreatic cancer touches families through a genetic susceptibility to developing this neoplasia. Genetic susceptibility is assessed via family history, genetic testing, or both. Individuals with two or more first-degree relatives or three or more relatives of any degree diagnosed with pancreatic cancer are considered at elevated risk. Following a diagnosis of familial pancreatic cancer, patients and families face uncertainty and anxiety about the future. Psychosocial effects of a pancreatic cancer diagnosis on families include fear, concerns about personal health, and how lifestyle may impact the risk of developing pancreatic cancer.

Case presentation

A 66-year-old male was diagnosed with pancreatic ductal adenocarcinoma stage IIB, T3, N1, M0. A genetic referral was made due to a history of multiple cases of pancreatic cancer within the patient’s family. Genetic testing revealed the patient had a pathogenic variant in the ATM gene that is associated with an increased risk for pancreatic cancer development. The patient’s one adult child was offered testing due to the autosomal dominant pattern of inheritance for this variant. The adult child was found to have the same pathogenic variant. She expressed fear for her future and her child’s future health and longevity. Discussing a case study allows us to capture the multi-faceted relationship between the disease, the affected individuals, and their families. Examining the psychosocial stresses and concerns when there is a pancreatic cancer diagnosis in the family is essential to provide holistic care to patients and families.

Conclusions

The psychosocial effects of FPC may be overwhelming for patients and families. Healthcare providers can offer education, support, and referrals to appropriate services to help families cope through stages of evaluation, diagnosis, and treatment of FPC.

Underhill M, Hong F, Lawrence J, Blonquist T, Syngal S. Relationship between individual and family characteristic and psychosocial factors in persons with familial pancreatic cancer. Psychooncology. 2018;27(7):1711–8. https://doi.org/10.1002/pon.4712.CrossRefPubMedPubMedCentral

Breitkopf C, Sinicrope PS, Rabe KG, et al. Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history. Hered Cancer Clin Pract. 2012;10(1):8. https://doi.org/10.1186/1897-4287-10-8.CrossRefPubMedPubMedCentral

Cancer.Net. Familial pancreatic cancer. 2021. Available from https://www.cancer.net/cancer-types/familial-pancreatic-cancer.

O’Neil RS, Meiser B, Emmanuel S, et al. Long-term positive outcomes in an Australian pancreatic cancer screening program. Fam Cancer. 2020;19:23–5. https://doi.org/10.1007/s10689-019-00147-3.CrossRef

Matsubayashi H, Taklori K, Morizane C, et al. Familial pancreatic cancer: concept, management, and issues. World J Gastroenterol. 2017;23(6):935–48. https://doi.org/10.3748/wjg.v23.i6.935.CrossRefPubMedPubMedCentral

Hann KEJ, Freeman M, Fraser L, et al. Awareness, knowledge, perceptions, and attitudes toward genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health. 2017;17(1):503. https://doi.org/10.1186/s12889-017-4375-8.CrossRefPubMedPubMedCentral

Underhill M, Berry D, Dalton E, Schienda J, Syngal S. Patient experiences living with pancreatic cancer risk. Hered Cancer Clin Pract. 2015;13(1):13. https://doi.org/10.1186/s13053-015-0034-1.CrossRefPubMedPubMedCentral

Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7–17. https://doi.org/10.1136/gutjnl-2019-319352.CrossRefPubMed

OMIM #607585. ATM Serine/threonine kinase, ATAXIA-TELANGIECTASIA. Available from https://omim.org/entry/607585?search=ATM&highlight=atm. Accessed 27 Feb 2023.

10.

Hsu F, Roberts NJ, Vet MB, et al. Risk of pancreatic cancer among individuals with pathogenic variants of the ATM gene. JAMA Oncol. 2021;7(11):1664–8. https://doi.org/10.1001/jammaoncol.2021.3701.CrossRefPubMed

11.

Kreis P, Gallrein C, Rojas-Puente E, et al. ATM phosphorylation of the actin-binding protein drebin controls oxidation stress-resistance in mammalian neurons and C. elegans. Nat Commun. 2019;10:486. https://doi.org/10.1038/s41467-019-08420-w.CrossRefPubMedPubMedCentral

12.

Tse K, Herrup K. Re-imagining Alzheimer’s disease-the diminishing importance of amyloid and a glimpse of what lies ahead. J Neurochem. 2017;143(4):432–44. https://doi.org/10.1111/jnc.14079.CrossRefPubMed

13.

Shen X, Chen J, Li J, et al. Neurons in vulnerable regions of the Alzheimer’s disease brain display reduced ATM signaling. eNeuro. 2016;3(1). https://doi.org/10.1523/ENEURO.0124-15.2016.

14.

Lee KG, Roy V, Lazlo M, et al. Symptom management in pancreatic cancer. Curr Treat Option Oncol. 2021;22(1):8. https://doi.org/10.1007/s11864-020-00801-4.CrossRef

15.

Clark KL, Loscalzo M, Trask PC, et al. Psychosocial distress in patients with pancreatic cancer-an understudied group. Psychooncology. 2010;10:1313–20. https://doi.org/10.1002/pon.1697.CrossRef

16.

Kenner B. Early detection of pancreatic cancer. The role of depression and anxiety as a precursor for disease. Pancreas. 2018;47(4):363–7. https://doi.org/10.1097/MPA.0000000000001024.CrossRefPubMedPubMedCentral

17.

Seoud T, Syed A, Carleton N, et al. Depression preceding and following a diagnosis of pancreatic cancer: results from a national, population-based study. Pancreas. 2020;49(8):1117–22. https://doi.org/10.1097/MPA.0000000000001635.CrossRefPubMedPubMedCentral

18.

Czerw A, Religioni U, Banas T. Perception of cancer in patients diagnosed with the most common gastrointestinal cancers. BMC Palliat Care. 2020;19(1):144. https://doi.org/10.1186/s12904-020-00650-w.CrossRefPubMedPubMedCentral

19.

van Rijssen LB, Gerritsen A, Henselmans I, et al. COPRAC study group. Core set of patient-reported outcomes in pancreatic cancer. Ann Surg. 2019;270:158–64. https://doi.org/10.1097/SLA.0000000000002633.CrossRefPubMed

20.

Sherman DW, Mcguire DB, Free D, et al. A pilot study of the experience of family caregivers of patients with advanced pancreatic cancer using a mixed methods approach. J Pain Symptom Manag. 2014;48(3):385-99.e1-2. https://doi.org/10.1016/j.jpainsymman.2013.09.006.CrossRef

21.

Koning IC, Harinck F, Kuenen MA, et al. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer. 2016;16(1):143–51. https://doi.org/10.1007/s10689-016-9930-4.CrossRef

22.

Maheu C, Vodermaier A, Rothenmund H, et al. Pancreatic cancer risk counseling and screening: impact on perceived risk and psychological functioning. Fam Cancer. 2010;9:617–24. https://doi.org/10.1007/s10689-010-9354-5.CrossRefPubMed

23.

Overbeek KA, Cahen DL, Kamps A, et al. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance. Fam Cancer. 2020;19:247–58. https://doi.org/10.1007/s10689-20-00171-8.CrossRefPubMedPubMedCentral

24.

Overbeek KA, Levink JM, Koopman BD, et al. Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut. 2021;17:1151–60. https://doi.org/10.1136/gutjnl-2021-324739.CrossRef

25.

Kim Y, Baek W. Caring experiences of family caregivers of patients with pancreatic cancer: an integrative review. Support Care Cancer. 2022;30:3691–700. https://doi.org/10.1007/s00520-021006793-7.CrossRefPubMed

26.

Janda M, Neale RE, Klein K, et al. Anxiety, depression and quality of life in people with pancreatic cancer and their carers. Pancreatology. 2017;17(2):321–7. https://doi.org/10.1016/j.pan.2017.01.008.CrossRefPubMed

27.

Chong E, Crowe L, Mentor K, et al. Systematic review of caregiver burden, unmet needs and quality-of-life among informal caregivers of patients with pancreatic cancer. Support Care Cancer. 2023;31:74. https://doi.org/10.1007/s00520-022-07468-7.CrossRef

28.

Kim H, Saka B, Knight S, et al. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with poor prognosis. Clin Cancer Res. 2014;20(7):1865–72. https://doi.org/10.1158/1078-0432.ccr-13-1239.CrossRefPubMedPubMedCentral

29.

Canto MI, Harinck F, Hruban RH, et al. 764 International consensus recommendations on the management of patients with increased risk for familial pancreatic cancer: cancer of the pancreas screening consortium (CAPS) 2011 summit. Gastroenterology. 2012;142(5). https://doi.org/10.1016/s0016-5085(12)60511-3.

Title: Familial pancreatic cancer: a case study and review of the psychosocial effects of diagnoses on families
Authors: Tracy Lowe
Jane DeLuca
Ludovico Abenavoli
Luigi Boccuto
Publication date: 01-12-2023
Publisher: BioMed Central
Keyword: Anxiety
Published in: Hereditary Cancer in Clinical Practice / Issue 1/2023
Electronic ISSN: 1897-4287
DOI: https://doi.org/10.1186/s13053-023-00261-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Genetic testing for hereditary breast cancer in Poland: 1998–2022

Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

Periampullary tumors in a patient with pancreatic divisum and neurofibromatosis type 1: a case report

Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres

Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria

SMAD4 variants and its genotype–phenotype correlations to juvenile polyposis syndrome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer